Brainsway Ltd - Asset Resilience Ratio
Brainsway Ltd (BWAY) has an Asset Resilience Ratio of 0.97% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check Brainsway Ltd (BWAY) strategic asset index to assess the company's strategic physical and investment asset allocation.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2012–2025)
This chart shows how Brainsway Ltd's Asset Resilience Ratio has changed over time. See BWAY net asset quality score to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down Brainsway Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Brainsway Ltd market capitalisation.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $1.14 Million | 0.97% |
| Total Liquid Assets | $1.14 Million | 0.97% |
Asset Resilience Insights
- Limited Liquidity: Brainsway Ltd maintains only 0.97% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Brainsway Ltd Industry Peers by Asset Resilience Ratio
Compare Brainsway Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Cochlear Ltd
AU:COH |
Medical Devices | 9.76% |
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
Jafron Biomedical Co Ltd
SHE:300529 |
Medical Devices | 39.15% |
|
HOB Biotech Group Corp Ltd
SHG:688656 |
Medical Devices | 2.62% |
|
Polynovo Ltd
AU:PNV |
Medical Devices | 0.04% |
|
Shanghai ZJ Bio-Tech Co. Ltd. A
SHG:688317 |
Medical Devices | 10.88% |
|
Dirui Industrial Co Ltd
SHE:300396 |
Medical Devices | 6.89% |
|
Emvision Medical Devices Ltd
AU:EMV |
Medical Devices | 0.06% |
Annual Asset Resilience Ratio for Brainsway Ltd (2012–2025)
The table below shows the annual Asset Resilience Ratio data for Brainsway Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 1.27% | $1.43 Million | $112.92 Million | -- |
| 2024-12-31 | 0.00% | $0.00 | $94.32 Million | -- |
| 2023-12-31 | 56.32% | $35.47 Million | $62.97 Million | +55.90pp |
| 2022-12-31 | 0.42% | $271.00K | $64.48 Million | -52.96pp |
| 2021-12-31 | 53.38% | $40.43 Million | $75.73 Million | +52.73pp |
| 2020-12-31 | 0.65% | $221.00K | $34.01 Million | +0.08pp |
| 2019-12-31 | 0.57% | $221.00K | $38.74 Million | +0.14pp |
| 2018-12-31 | 0.43% | $101.00K | $23.60 Million | +0.24pp |
| 2017-12-31 | 0.18% | $50.00K | $27.03 Million | -2.75pp |
| 2016-12-31 | 2.93% | $585.00K | $19.96 Million | +0.30pp |
| 2015-12-31 | 2.63% | $585.00K | $22.24 Million | -1.56pp |
| 2014-12-31 | 4.19% | $1.08 Million | $25.77 Million | -3.98pp |
| 2013-12-31 | 8.16% | $1.46 Million | $17.85 Million | -1.74pp |
| 2012-12-31 | 9.91% | $1.06 Million | $10.70 Million | -- |
About Brainsway Ltd
BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious and late-life depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post-traumatic stress disorders, … Read more